Can a simple injection speed up hip replacement recovery?
NCT ID NCT07498660
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether injecting platelet-rich plasma (PRP) into the sacroiliac joint after hip replacement surgery can help people recover faster and have less pain. About 60 adults with hip arthritis who are scheduled for a hip replacement will take part. Half will get the PRP injection and half will get a placebo (salt water), and their progress will be tracked for 12 weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Apr 2026
An estimate. Start dates often move.
- Expected to finish
-
Mar 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
45 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * primary osteoarthritis of the hip; * qualification for elective total hip arthroplasty (THA); * age ≥45 years; * written informed consent; * ability to understand Polish. Exclusion Criteria: * prior surgical treatment of the hip or sacroiliac joint; * malignancy; * developmental dysplasia of the hip; * rheumatologic diseases (rheumatoid arthritis, ankylosing spondylitis, juvenile idiopathic arthritis); * neurological or psychiatric disorders; * allergy to local anesthetics.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hip arthroplasty, total are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Department of Orthopaedics and Rehabilitation, Medical University of Warsaw
Warsaw, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Inside or outside the knee: which steroid injection spot eases arthritis pain better?
- Can a targeted nerve block beat spinal morphine for hip surgery pain?
- Can your own cells ease osteoarthritis pain?
- Blocking knee blood vessels may offer new pain relief for severe osteoarthritis
- Could a pinch of radiation ease arthritis pain?
- Hip replacement recovery goes digital: app-based rehab tested against standard care